Lifetime Risk of Developing or Dying From Cancer
Learn about the chance each person has of being diagnosed with or dying from different types of cancer during his or her lifetime.
Learn about the chance each person has of being diagnosed with or dying from different types of cancer during his or her lifetime.
Join us for an enlightening episode of “Inside the Mind of a Neurosurgeon,” where we sit down with Dr. John Boockvar, a renowned neurosurgeon at…
Moderated by Dr. Hendifar, Cedars-Sinai and Dr. Lashkari, MOASC President and Oncologist at Wellness Oncology with discussants Jun Gong, MD, Cedars-Sinai and Zev Wainberg, MD,…
With an estimated 65 million individuals affected by post-COVID-19 condition (also known as long COVID),1 non-invasive biomarkers are direly needed to guide clinical management. To…
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…
AACR Special Conference in Cancer Research: Expanding and Translating Cancer Synthetic Vulnerabilities
Presented by The Rivkin Center for Ovarian Cancer and the AACR September 20-21, 2024Seattle Airport Marriott HotelSeattle, Washington Symposium Cochairs Joyce F. Liu, Dana-Farber Cancer…
Gay City: Seattle’s LGBTQ Center creates access and connections to LGBTQ-affirming resources, wellness and community.
Fourth AACR International Meeting In cooperation with the International Conference on Malignant Lymphoma (ICML)In association with Blood Cancer Discovery June 19-22, 2024 Sheraton Philadelphia DowntownPhiladelphia,…
A funding opportunity for individuals across the educational continuum to facilitate continued support in projects that make progress towards inclusive excellence at the Stanford Cancer…
With an estimated 65 million individuals affected by post-COVID-19 condition (also known as long COVID),1 non-invasive biomarkers are direly needed to guide clinical management. To…